https://www.biospace.com/article/bayer-poaches-gsk-s-christine-roth-editas-terminates-cmo-other-executive-moves

Sandrock Finds Another Board Appointment

Alfred Sandrock, the former head of R&D at Biogen, found a role as the second board of directors one week after he was appointed to the board of directors at Voyager Therapeutics. This morning, Bay Area-based Verge Genomics announced Sandrock has joined its board of directors.